In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...